These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7691361)

  • 1. Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract.
    Guelstein VI; Tchipysheva TA; Ermilova VD; Troyanovsky SM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(1):1-5. PubMed ID: 7691361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.
    Schaafsma HE; Ramaekers FC; van Muijen GN; Lane EB; Leigh IM; Robben H; Huijsmans A; Ooms EC; Ruiter DJ
    Am J Pathol; 1990 Feb; 136(2):329-43. PubMed ID: 1689541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
    Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
    Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel.
    Tamboli P; Mohsin SK; Hailemariam S; Amin MB
    Arch Pathol Lab Med; 2002 Sep; 126(9):1057-63. PubMed ID: 12204054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Needle aspiration cytology of metastatic high-grade transitional-cell carcinomas of the urinary tract.
    Ho CC; Nguyen GK; Schumann GB
    Diagn Cytopathol; 1998 Jun; 18(6):409-15. PubMed ID: 9626512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.
    Harnden P; Southgate J
    J Clin Pathol; 1997 Dec; 50(12):1032-3. PubMed ID: 9516889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
    Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
    Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].
    Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A
    Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens.
    Sack MJ; Roberts SA
    Diagn Cytopathol; 1997 Feb; 16(2):132-6. PubMed ID: 9067104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of keratin subtyping in transitional cell carcinoma of the upper urinary tract.
    Langner C; Wegscheider BJ; Rehak P; Ratschek M; Zigeuner R
    Virchows Arch; 2004 Nov; 445(5):442-8. PubMed ID: 15378357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.
    Moll R; Wu XR; Lin JH; Sun TT
    Am J Pathol; 1995 Nov; 147(5):1383-97. PubMed ID: 7485401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.
    Langner C; Ratschek M; Tsybrovskyy O; Schips L; Zigeuner R
    J Histochem Cytochem; 2003 Aug; 51(8):1097-9. PubMed ID: 12871991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.
    Schaafsma HE; Ramaekers FC; van Muijen GN; Robben H; Lane EB; Leigh IM; Ooms EC; Schalken JA; van Moorselaar RJ; Ruiter DJ
    Am J Pathol; 1991 Dec; 139(6):1389-400. PubMed ID: 1721491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
    J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
    Ordóñez NG
    Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.